Follicle-Stimulating Hormone-Secreting Pituitary Adenoma Inducing Spontaneous Ovarian Hyperstimulation Syndrome, Treatment Using Fertilization and Embryo Transfer: A Case Report

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2021 Jul 12

PMID 34248835

Citations 3

Authors

Xiaofang Du

Wen Zhang

Xingling Wang

Xiaona Yu

Zhen Li

Yichun Guan

Affiliations

Soon will be listed here.

Abstract

Objective: To describe the management of a patient with a pituitary adenoma secreting follicle-stimulating hormone (FSH) associated with spontaneous ovarian hyperstimulation syndrome (sOHSS) who was treated with fertilization and embryo transfer (IVF-ET).

Methods: We report a clinical case of a woman of reproductive age with menstrual irregularity, infertility and ovarian hyperstimulation due to recurrent pituitary adenoma secreting FSH, which persisted after transsphenoidal surgery.She underwent the diagnosis by magnetic resonance imaging (MRI) and laboratory tests,and finally she was treated with IVF-ET.

Results: The patient was plagued by a recurrent pituitary adenoma for many years and tried various treatments. After complete transsphenoidal surgery, sOHSS decreased, as shown by a reduction in oestradiol levels and an improvement in the ultrasonography parameters; however, secondary amenorrhea occurred. Finally, pregnancy was achieved through IVF-ET and the symptoms of ovarian hyperstimulation were relieved.

Conclusions: IVF-ET was found to be effective for the treatment of recurrent pituitary adenoma, thus representing a therapeutic option that should be taken into consideration in such cases.

Citing Articles

Prognostic Factors for Invasiveness and Recurrence of Pituitary Adenomas: A Series of 94 Patients.

Stefanidis P, Kyriakopoulos G, Seretis A, Korfias S, Theocharis S, Angelousi A Diagnostics (Basel). 2022; 12(10).

PMID: 36292101 PMC: 9600140. DOI: 10.3390/diagnostics12102413.

Optimal waiting period for frozen embryo transfer after hysteroscopic polypectomy: A propensity score matching analysis.

Wang B, Meng N, Zhang W, Kong P, Liu Z, Liu W Front Endocrinol (Lausanne). 2022; 13:986809.

PMID: 36246905 PMC: 9561364. DOI: 10.3389/fendo.2022.986809.

Updating the Landscape for Functioning Gonadotroph Tumors.

Ntali G, Capatina C Medicina (Kaunas). 2022; 58(8).

PMID: 36013538 PMC: 9414558. DOI: 10.3390/medicina58081071.

References

Cabar F . Ovarian hyperstimulation syndrome in a spontaneous singleton pregnancy. Einstein (Sao Paulo). 2016; 14(2):231-4. PMC: 4943359. DOI: 10.1590/S1679-45082016RC3429. View

Ghayuri M, Liu J . Ovarian hyperstimulation syndrome caused by pituitary gonadotroph adenoma secreting follicle-stimulating hormone. Obstet Gynecol. 2007; 109(2 Pt2):547-9. DOI: 10.1097/01.AOG.0000247316.60573.4a. View

Christin-Maitre S, Kottler M, Lahlou N, Frydman R, Touraine P, Bouchard P . A spontaneous and severe hyperstimulation of the ovaries revealing a gonadotroph adenoma. J Clin Endocrinol Metab. 1998; 83(10):3450-3. DOI: 10.1210/jcem.83.10.5182. View

De Leener A, Montanelli L, Van Durme J, Chae H, Smits G, Vassart G . Presence and absence of follicle-stimulating hormone receptor mutations provide some insights into spontaneous ovarian hyperstimulation syndrome physiopathology. J Clin Endocrinol Metab. 2005; 91(2):555-62. DOI: 10.1210/jc.2005-1580. View

Ho D, Hsu C, Ting L, Chiang H . The clinicopathological characteristics of gonadotroph cell adenoma: a study of 118 cases. Hum Pathol. 1997; 28(8):905-11. DOI: 10.1016/s0046-8177(97)90005-8. View

Shimon I, Rubinek T, Bar-Hava I, Nass D, Hadani M, Amsterdam A . Ovarian hyperstimulation without elevated serum estradiol associated with pure follicle-stimulating hormone-secreting pituitary adenoma. J Clin Endocrinol Metab. 2001; 86(8):3635-40. DOI: 10.1210/jcem.86.8.7766. View

Djerassi A, Coutifaris C, West V, Asa S, Kapoor S, Pavlou S . Gonadotroph adenoma in a premenopausal woman secreting follicle-stimulating hormone and causing ovarian hyperstimulation. J Clin Endocrinol Metab. 1995; 80(2):591-4. DOI: 10.1210/jcem.80.2.7852525. View

De Leener A, Caltabiano G, Erkan S, Idil M, Vassart G, Pardo L . Identification of the first germline mutation in the extracellular domain of the follitropin receptor responsible for spontaneous ovarian hyperstimulation syndrome. Hum Mutat. 2007; 29(1):91-8. DOI: 10.1002/humu.20604. View

Halupczok J, Bidzinska-Speichert B, Lenarcik-Kabza A, Zielinski G, Filus A, Maksymowicz M . Gonadotroph adenoma causing ovarian hyperstimulation syndrome in a premenopausal woman. Gynecol Endocrinol. 2014; 30(11):774-7. DOI: 10.3109/09513590.2014.934668. View

10.

Caretto A, Lanzi R, Piani C, Molgora M, Mortini P, Losa M . Ovarian hyperstimulation syndrome due to follicle-stimulating hormone-secreting pituitary adenomas. Pituitary. 2017; 20(5):553-560. DOI: 10.1007/s11102-017-0817-7. View

11.

Garmes H, Grassiotto O, Fernandes Y, de Souza Queiroz L, Vassalo J, de Oliveira D . A pituitary adenoma secreting follicle-stimulating hormone with ovarian hyperstimulation: treatment using a gonadotropin-releasing hormone antagonist. Fertil Steril. 2011; 97(1):231-4. DOI: 10.1016/j.fertnstert.2011.10.015. View

12.

Castelbaum A, Bigdeli H, Post K, Freedman M, Snyder P . Exacerbation of ovarian hyperstimulation by leuprolide reveals a gonadotroph adenoma. Fertil Steril. 2002; 78(6):1311-3. DOI: 10.1016/s0015-0282(02)04342-x. View

13.

Lania A, Gangi E, Romoli R, Losa M, Travaglini P, Meringolo D . Impaired estrogen-induced negative feedback on gonadotropin secretion in patients with gonadotropin-secreting and nonfunctioning pituitary adenomas. Eur J Clin Invest. 2002; 32(5):335-40. DOI: 10.1046/j.1365-2362.2002.00981.x. View

14.

Katulande P, Kariyawasam S, Senanayake H, Weerakkodi M . Multicystic ovaries and pituitary pseudo-adenoma associated with primary hypothyroidism. J Obstet Gynaecol. 2012; 33(1):17-9. DOI: 10.3109/01443615.2011.565388. View

15.

Kanaya M, Baba T, Kitajima Y, Ikeda K, Shimizu A, Morishita M . Continuous follicle-stimulating hormone exposure from pituitary adenoma causes periodic follicle recruitment and atresia, which mimics ovarian hyperstimulation syndrome. Int J Womens Health. 2012; 4:427-31. PMC: 3469228. DOI: 10.2147/IJWH.S33386. View

16.

Sugita T, Seki K, Nagai Y, Saeki N, Yamaura A, Ohigashi S . Successful pregnancy and delivery after removal of gonadotrope adenoma secreting follicle-stimulating hormone in a 29-year-old amenorrheic woman. Gynecol Obstet Invest. 2005; 59(3):138-43. DOI: 10.1159/000083087. View

17.

Yamada S, Ohyama K, Taguchi M, Takeshita A, Morita K, Takano K . A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas. Neurosurgery. 2007; 61(3):580-4. DOI: 10.1227/01.NEU.0000290906.53685.79. View

18.

Mayson S, Snyder P . Silent (clinically nonfunctioning) pituitary adenomas. J Neurooncol. 2014; 117(3):429-36. DOI: 10.1007/s11060-014-1425-2. View

19.

Skoric T, Grubisic G, Korsic M, Besenski N, Paladino J, Plavsic V . Evolution of clinical symptoms in a young woman with a recurrent gonadotroph adenoma causing ovarian hyperstimulation. Eur J Endocrinol. 2000; 143(5):607-14. DOI: 10.1530/eje.0.1430607. View

20.

Cooper O, Geller J, Melmed S . Ovarian hyperstimulation syndrome caused by an FSH-secreting pituitary adenoma. Nat Clin Pract Endocrinol Metab. 2008; 4(4):234-8. PMC: 2777809. DOI: 10.1038/ncpendmet0758. View